Home / Auditor changes / BridgeBio Oncology Therapeutics, Inc.
Filed 2025-08-13 路 Form 8-K 路 Accession 0001213900-25-075190 micro
Price before filing: $9.9 (2025-08-11 close, split/dividend-adjusted)
Market cap at flag: $232.7M (2025-08-11) 路 Latest: $232.7M (2025-08-11)
| Window | HLXB | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | n/a | n/a | n/a | no price after 2025-08-11 |
| 90 days | n/a | n/a | n/a | no price after 2025-08-11 |
| 180 days | n/a | n/a | n/a | no price after 2025-08-11 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"On August 11, 2025, PubCo Board dismissed WithumSmith+Brown, PC ("Withum"), the independent registered public accounting firm of Helix prior to the Business Combination, as the independent registered public accounting firm of PubCo."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: routine (post-merger auditor consolidation)
Disagreements reported: no
Former auditor: WithumSmith+Brown, PC · New auditor: Deloitte & Touche LLP
Why this score: routine: auditor replaced after company merger/SPAC deal; also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.